These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 27871021)

  • 1. Stop codons in the hepatitis B surface proteins are enriched during antiviral therapy and are associated with host cell apoptosis.
    Colledge D; Soppe S; Yuen L; Selleck L; Walsh R; Locarnini S; Warner N
    Virology; 2017 Jan; 501():70-78. PubMed ID: 27871021
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nucleos(t)ide analogues causes HBV S gene mutations and carcinogenesis.
    Wang ML; Tang H
    Hepatobiliary Pancreat Dis Int; 2016 Dec; 15(6):579-586. PubMed ID: 27919846
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complementation of Wild-Type and Drug-Resistant Hepatitis B Virus Genomes to Maintain Viral Replication and Rescue Virion Production under Nucleos(t)ide Analogs.
    Wu C; Li B; Zhang X; Zhao K; Chen Y; Yuan Y; Liu Y; Chen R; Xu D; Chen X; Lu M
    Virol Sin; 2019 Aug; 34(4):377-385. PubMed ID: 31218588
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of the hepatitis B virus polymerase rtA181T mutation on replication and drug resistance is potentially affected by overlapping changes in surface gene.
    Ahn SH; Park YK; Park ES; Kim JH; Kim DH; Lim KH; Jang MS; Choe WH; Ko SY; Sung IK; Kwon SY; Kim KH
    J Virol; 2014 Jun; 88(12):6805-18. PubMed ID: 24696492
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune-escape mutations and stop-codons in HBsAg develop in a large proportion of patients with chronic HBV infection exposed to anti-HBV drugs in Europe.
    Colagrossi L; Hermans LE; Salpini R; Di Carlo D; Pas SD; Alvarez M; Ben-Ari Z; Boland G; Bruzzone B; Coppola N; Seguin-Devaux C; Dyda T; Garcia F; Kaiser R; Köse S; Krarup H; Lazarevic I; Lunar MM; Maylin S; Micheli V; Mor O; Paraschiv S; Paraskevis D; Poljak M; Puchhammer-Stöckl E; Simon F; Stanojevic M; Stene-Johansen K; Tihic N; Trimoulet P; Verheyen J; Vince A; Lepej SZ; Weis N; Yalcinkaya T; Boucher CAB; Wensing AMJ; Perno CF; Svicher V;
    BMC Infect Dis; 2018 Jun; 18(1):251. PubMed ID: 29859062
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High frequency of complex mutational patterns in lamivudine resistant hepatitis B virus isolates.
    Neumann-Fraune M; Beggel B; Pfister H; Kaiser R; Verheyen J
    J Med Virol; 2013 May; 85(5):775-9. PubMed ID: 23408582
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatitis B Virus preS/S Truncation Mutant rtM204I/sW196* Increases Carcinogenesis through Deregulated
    Lai MW; Liang KH; Yeh CT
    Int J Mol Sci; 2020 Sep; 21(17):. PubMed ID: 32887289
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Possible Involvement of Multidrug-Resistant Hepatitis B Virus sW172* Truncation Variant in the ER Stress Signaling Pathway during Hepatocarcinogenesis.
    Zheng J; Jiang S; Lu F
    Jpn J Infect Dis; 2016 Jul; 69(4):306-13. PubMed ID: 26567840
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The antiviral drug selected hepatitis B virus rtA181T/sW172* mutant has a dominant negative secretion defect and alters the typical profile of viral rebound.
    Warner N; Locarnini S
    Hepatology; 2008 Jul; 48(1):88-98. PubMed ID: 18537180
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduction of hepatitis B surface antigen and covalently closed circular DNA by nucleos(t)ide analogues of different potency.
    Wong DK; Seto WK; Fung J; Ip P; Huang FY; Lai CL; Yuen MF
    Clin Gastroenterol Hepatol; 2013 Aug; 11(8):1004-10.e1. PubMed ID: 23376799
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The rtL229 substitutions in the reverse transcriptase region of hepatitis B virus (HBV) polymerase are potentially associated with lamivudine resistance as a compensatory mutation.
    Ji D; Liu Y; Li L; Xu Z; Si LL; Dai JZ; Li X; Wang L; Yao Z; Xin SJ; Chen GF; Xu D
    J Clin Virol; 2012 May; 54(1):66-72. PubMed ID: 22398037
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis B virus reactivation in patients receiving chemotherapy for malignancies: role of precore stop-codon and basic core promoter mutations.
    Alexopoulou A; Theodorou M; Dourakis SP; Karayiannis P; Sagkana E; Papanikolopoulos K; Archimandritis AJ
    J Viral Hepat; 2006 Sep; 13(9):591-6. PubMed ID: 16907845
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prophylaxis against hepatitis B virus recurrence after liver transplantation: a registry study.
    Shen S; Jiang L; Xiao GQ; Yan LN; Yang JY; Wen TF; Li B; Wang WT; Xu MQ; Wei YG
    World J Gastroenterol; 2015 Jan; 21(2):584-92. PubMed ID: 25593480
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatitis B virus genetic diversity.
    Echevarría JM; Avellón A
    J Med Virol; 2006; 78 Suppl 1():S36-42. PubMed ID: 16622876
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of a premature stop codon in the surface gene of hepatitis B virus from an HBsAg and antiHBc negative blood donor.
    Datta S; Banerjee A; Chandra PK; Chakraborty S; Basu SK; Chakravarty R
    J Clin Virol; 2007 Nov; 40(3):255-8. PubMed ID: 17869170
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic variants of hepatitis B virus and their clinical relevance.
    Baumert TF; Barth H; Blum HE
    Minerva Gastroenterol Dietol; 2005 Mar; 51(1):95-108. PubMed ID: 15756149
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Occult infection related hepatitis B surface antigen variants showing lowered secretion capacity.
    Kim H; Lee SA; Won YS; Lee H; Kim BJ
    World J Gastroenterol; 2015 Feb; 21(6):1794-803. PubMed ID: 25684944
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatitis B virus surface antigen and polymerase gene variants: potential virological and clinical significance.
    Locarnini SA
    Hepatology; 1998 Jan; 27(1):294-7. PubMed ID: 9425951
    [No Abstract]   [Full Text] [Related]  

  • 19. Functional analysis of HBV genomes from patients with fulminant hepatitis.
    Sterneck M; Kalinina T; Günther S; Fischer L; Santantonio T; Greten H; Will H
    Hepatology; 1998 Nov; 28(5):1390-7. PubMed ID: 9794926
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiviral effect of Curcuma longa Linn extract against hepatitis B virus replication.
    Kim HJ; Yoo HS; Kim JC; Park CS; Choi MS; Kim M; Choi H; Min JS; Kim YS; Yoon SW; Ahn JK
    J Ethnopharmacol; 2009 Jul; 124(2):189-96. PubMed ID: 19409970
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.